Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Extending nature's leads: the anticancer agent ellipticine.

Nichola C Garbett1, David E Graves

  • 1Department of Chemistry, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA.

Current Medicinal Chemistry. Anti-Cancer Agents
|March 23, 2004
PubMed
Summary

Ellipticine, a natural anticancer compound, binds to DNA and penetrates cell membranes. Structural modifications yield analogs with improved efficacy and reduced toxicity for cancer therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Automated Baseline-Correction and Signal-Detection Algorithms with Web-Based Implementation for Thermal Liquid Biopsy Data Analysis.

Cancers·2026
Same author

Evaluation of Thermal Liquid Biopsy Analysis of Saliva and Blood Plasma Specimens as a Novel Diagnostic Modality in Head and Neck Cancer.

Cancers·2025
Same author

Characterization of myocardial injury phenotype by thermal liquid biopsy.

Frontiers in cardiovascular medicine·2024
Same author

Plasma Thermogram Parameters Differentiate Status and Overall Survival of Melanoma Patients.

Current oncology (Toronto, Ont.)·2023
Same author

Sample Processing Considerations for Protein Stability Studies of Low Concentration Biofluid Samples using Differential Scanning Calorimetry.

Protein and peptide letters·2022
Same author

The Utility of Differential Scanning Calorimetry Curves of Blood Plasma for Diagnosis, Subtype Differentiation and Predicted Survival in Lung Cancer.

Cancers·2021

Area of Science:

  • Natural Products Chemistry
  • Medicinal Chemistry
  • Pharmacology

Background:

  • Ellipticine, isolated from an Australian tree, is a promising anticancer agent.
  • Its planar structure facilitates DNA intercalation with high binding affinity.
  • Unique protonatable nitrogens influence its behavior under physiological conditions.

Purpose of the Study:

  • To explore the anticancer potential of ellipticine and its analogs.
  • To understand the mechanism of action, including DNA binding and enzyme interactions.
  • To guide rational drug design for improved anticancer therapies.

Main Methods:

  • Isolation and structural characterization of ellipticine.
  • Investigation of DNA binding interactions and affinity.
  • Synthesis and evaluation of ellipticine analogs for anticancer activity.
  • Exploration of mechanisms involving topoisomerase II and telomerase.

Main Results:

  • Ellipticine exhibits high DNA binding affinity via intercalation.
  • Both charged and uncharged species contribute to its biological activity.
  • Structurally modified ellipticine analogs show enhanced anticancer properties and reduced toxicity.
  • Multiple modes of action, including enzyme inhibition, are implicated.

Conclusions:

  • Ellipticine and its derivatives represent a valuable class of anticancer drugs.
  • Rational drug design has successfully improved their therapeutic profile.
  • Further research into mechanisms will optimize future drug development.

Related Experiment Videos